Ebro Foods


2020: Ebro's year

26/02/21 -"Unsurprising very strong FY20 results (but still even more than our expectations). We believe Ebro is at a turning point and we continue to be positive on the stock. "

Pages
43
Language
English
Published on
26/02/21
You may also be interested by these reports :
06/04/21
So much has happened in such a short space of time. CEO Faber’s departure, which seemed highly unlikely a few months ago, has now been acted upon ...

26/03/21
We have positively revised our earnings forecasts in light of the sale of the underperforming North American division, although FY21 is marked by low ...

24/03/21
We have integrated the FY20 figures and revised our estimates, although there is a lack of visibility in the earnings trajectory. Following the ...

15/03/21
H1 performance still strongly impacted by COVID-19-related issues. The North American business divestment is, however, very welcomed at a price which ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO